Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A2 | P43004 | 2/20 | 0.54 |
| ▸ | CA2 | P00918 | 7/20 | 0.50 |
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | ACE | P12821 | 2/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.48 |
| ▸ | CTSL | P07711 | 2/20 | 0.47 |
| ▸ | CTSB | P07858 | 1/20 | 0.47 |
| ▸ | CTSS | P25774 | 1/20 | 0.47 |
| ▸ | CTSK | P43235 | 1/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.46 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.46 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.46 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27885368 | 1.00 | SLC1A2 (0.54) | SLC1A2CA2CA1ACEPTPN1 | |
| SCHEMBL8053213 | 0.84 | ACE (0.52) | SLC1A2CA2CA1ACEPTPN1 | |
| SCHEMBL8787239 | 0.81 | SLC1A2 (0.49) | SLC1A2CA2CA1ACEPTPN1 | |
| D-Phenylalanine SCHEMBL10761946 | 0.81 | CA2 (0.65) | CA2CA1ACEPTPN1CTSL | |
| Phenylalanine SCHEMBL10760080 | 0.81 | CA2 (0.65) | CA2CA1ACEPTPN1CTSL | |
| SCHEMBL4465251 | 0.81 | CTSL (0.67) | CA2CA1CTSLCTSBCTSS | |
| SCHEMBL2158906 | 0.81 | CTSL (0.67) | CA2CA1CTSLCTSBCTSS | |
| SCHEMBL2158900 | 0.81 | CTSL (0.67) | CA2CA1CTSLCTSBCTSS | |
| SCHEMBL30743610 | 0.81 | SLC1A2 (0.54) | SLC1A2CA2CA1ACEPTPN1 | |
| SCHEMBL1640054 | 0.80 | NAALAD2 (0.58) | CA2CA1ACEPTPN1CTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12564592-B1 | Injectable leucovorin formulations and methods of preparing same | Riconpharma LLC | 2026-03-03 | — | — | US | claimed |
| CN-102612358-A | Stabilised particles comprising 5-methyl-(6s)-tetrahydrofolate | BAYER SCHERING PHARMA AG | 2012-07-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12564592-B1 | Injectable leucovorin formulations and methods of preparing same | FGF23, MTHFD1, SI | SLC1A2 2031/4885CA2 286/4885CA1 971/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.